<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The urinary trypsin inhibitor (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e>) levels in the urine of patients with various <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e> were determined, using automated latex agglutination immunoturbidimetry </plain></SENT>
<SENT sid="1" pm="."><plain>The mean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> levels in urine in <z:hpo ids='HP_0011009'>acute</z:hpo> non-lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> groups were significantly elevated, compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> control group </plain></SENT>
<SENT sid="2" pm="."><plain>It was found that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">UTI</z:e> level in urine changed from an elevated value to a <z:mpath ids='MPATH_458'>normal</z:mpath> value with haematological improvement by chemotherapy in a patient with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> included in a previous study </plain></SENT>
<SENT sid="3" pm="."><plain>These results suggest tha </plain></SENT>
</text></document>